Development and Immunophenotyping of Squamous Cell Carcinoma Xenografts: Tools for Translational Immunology
Wei Lin(Florida Hospital Cancer Institute), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Xioayu Zhang(University of Maryland, Baltimore), Zhaorong Chen(University of Maryland, Baltimore), Steve Voss(Mayo Clinic), Schuyler O. Sanderson(Mayo Clinic), Linda Murphy(Mayo Clinic), Peter J. Wettstein, Nancy D. Borson(Mayo Clinic)
Cited by 5
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
|The Lancet Respiratory Medicine|2019|937
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548